Mitobronitol

Mitobronitol is a chemotherapy drug that is used in the treatment of various types of cancer. It is a type of alkylating agent, which works by damaging the DNA of cancer cells and preventing them from dividing and growing.

History

Mitobronitol was first synthesized in the 1960s as part of a series of compounds designed to be used in chemotherapy. It was initially used in the treatment of lung cancer, but has since been used to treat a variety of other cancers.

Mechanism of Action

As an alkylating agent, Mitobronitol works by binding to the DNA in cancer cells and causing damage. This damage prevents the cancer cells from dividing and growing, which can slow or stop the growth of the cancer.

Uses

Mitobronitol is used in the treatment of a variety of cancers, including lung cancer, breast cancer, and ovarian cancer. It is often used in combination with other chemotherapy drugs to increase its effectiveness.

Side Effects

Like all chemotherapy drugs, Mitobronitol can cause a range of side effects. These can include nausea, vomiting, hair loss, and fatigue. More serious side effects can include anemia, neutropenia, and thrombocytopenia.

See Also

• Chemotherapy
• Alkylating agent
• Cancer treatment

This Chemotherapy related article is a stub. You can help WikiMD by expanding it.

Mitobronitol

• 
  Mitobronitol